Clinical Trial

Assessment of Organ Failure Risk Predictions in ICU

Study acronym: AI4ICU-Obs
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
During this observational study, the investigators aim to assess the ability of ICU clinicians to predict the risk of impending organ failure and retrospectively compare it to the performance of previously published machine learning models. The central hypothesis of this study is that the treating physician can predict impending organ failure in adult ICU patients with similar accuracy as the best previously publishes machine learning models.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-03.
Status change: Recruiting → Active, Not Recruiting 2025-08-27
Trial Details
NCT Number NCT06814327
Lead Sponsor ETH Zurich
Collaborators: Insel Gruppe AG, University Hospital Bern
Conditions Circulatory Failure, Respiratory Failure, Renal Failure
Enrollment 499 participants
Start Date 2024-11-18
Primary Completion 2025-05-15 (estimated)
Study Completion 2026-05-15 (estimated)
Updated on ClinicalTrials.gov 2025-08-28